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biology. Thus, microbial susceptibility to various NO-
related molecules has not been fully elucidated.
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it is not found in higher eukaryotes [2, 3]. In contrast,
GSNO reductase is conserved from bacteria to humans
Summary and has been shown to reduce GSNO to ammonia and
glutathione disulphide (GSSG) [4]. We identified the C.
Enzymes that protect cells from reactive oxygen spe- neoformans genes encoding flavohemoglobin denitro-
cies (superoxide dismutase, catalase, peroxidase) sylase and GSNO reductase by searching the Stanford
have well-established roles in mammalian biology and and TIGR C. neoformans genome sequence databases
microbial pathogenesis. Two recently identified en- with the Saccharomyces cerevisiae YHB1 and SFA1
zymes detoxify nitric oxide (NO)-related molecules; gene sequences. The C. neoformans FHB1 gene encod-
flavohemoglobin denitrosylase consumes NO, and ing flavohemoglobin and the GNO1 gene encoding
S-nitrosoglutathione (GSNO) reductase metabolizes GSNO reductase were cloned and sequenced, and both
GSNO [1–6]. Although both enzymes protect microor- were present in single copy in the genome. Comparison
ganisms from nitrosative challenge in vitro, their rele- of genomic and cDNA sequences revealed that the FHB1
vance has not been established in physiological con- and GNO1 genes encode predicted products of 403 and
texts. Here we studied their biological functions in 383 amino acids that share 31% and 67% identity to
Cryptococcus neoformans, an established human fun- the S. cerevisiae Yhb1 and Sfa1 enzymes, respectively.
gal pathogen that replicates in macrophages and To evaluate the functions of flavohemoglobin and
whose growth in vitro and in infected animals is con- GSNO reductase in C. neoformans, we disrupted the
trolled by NO bioactivity [7–11]. We show that both FHB1 and GNO1 genes individually and in combination,
flavohemoglobin denitrosylase and GSNO reductase and the resulting mutant strains were evaluated for NO
contribute to C. neoformans pathogenesis. FHB1 and and GSNO resistance (Figure 1). The FHB1 and GNO1
GNO1 mutations abolished NO- and GSNO-consuming genes were not essential for vegetative growth; how-
activity, respectively. Growth of fhb1 mutant cells was ever, when NO consumption was assayed in wild-type,
inhibited by nitrosative challenge, whereas that of fhb1 mutant, fhb1  FHB1 reconstituted, and gno1 mu-
gno1 mutants was not. fhb1 mutants showed attenu- tant strains, no NO consumption was detected in fhb1
ated virulence in a murine model, and virulence was mutant cells in contrast to wild-type cells, which exhib-
restored in iNOS/ animals. Survival of the fhb1 mu- ited robust NO consumption. Reintroduction of the
tant was also reduced in activated macrophages and FHB1 gene at its endogenous locus restored the ability
restored to wild-type by inhibition of NOS activity. of the fhb1 mutant strain to metabolize NO (Figure 1A),
Combining mutations in flavohemoglobin and GSNO demonstrating that flavohemoglobin metabolizes NO in
reductase, or flavohemoglobin and superoxide dismu- C. neoformans. GSNO reductase did not contribute to
tase, further attenuated virulence. These studies illus- NO consumption (analyzed with several independent
trate that fungal pathogens elaborate enzymatic de- gno1 mutants lacking GSNO reductase activity) (data
fenses against nitrosative stress mounted by the host. not shown and Figure 1B). Conversely, extracts of the
gno1 mutant lacked GSNO metabolic activity, whereas
wild-type and fhb1 mutant cell extracts were fully com-Results and Discussion
petent in consuming GSNO (Figure 1B).
In the presence of an NO donor, the fhb1 mutant wasReactive oxygen and nitrogen species play important
hypersensitive to NO; growth was abolished by 1 mMroles in host defense, and microbes counteract these
DETA NONOate, whereas the wild-type and gno1 mutantmolecules with specific detoxifying enzymes. But al-
proliferated normally. GSNO reductase did not compen-though targeted deletion of antioxidant enzymes (SOD
sate for the loss of flavohemoglobin at this concentrationand catalase) has established incontrovertible antimi-
(Figure 2B). When DETA NONOate was removed fromcrobial roles for O2 and H2O2, respectively, genetic tests
the medium, growth of the fhb1 mutant resumed, indi-of relevance have not been applied in studies of NO
cating that NO exerts a fungistatic rather than fungicidal
effect under these conditions (not shown). Surprisingly,
the fhb1 mutant was also hypersensitive to the cyto-*Correspondence: heitm001@duke.edu
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Figure 1. Disruption of the FHB1 and GNO1 Genes
(A) Schematic diagram depicting FHB1 gene disruption with a PCR-generated fhb1::URA5 allele. E  EcoRI. Genomic DNA from wild-type,
fhb1 mutant, and fhb1  FHB1 reconstituted strains was EcoRI-digested and analyzed by Southern blot. (The FHB1 gene is 8.5 kb [open
arrowhead], and the fhb1::URA5 allele is 10.2 kb [closed arrowhead]). NO (approximately 1 mM) was added to buffer (circles) and to intact
cells of wild-type (squares), fhb1 mutant (triangles), and fhb1  FHB1 reconstituted (diamonds) strains, and NO levels were monitored with
an NO electrode.
(B) Schematic diagram depicting GNO1 gene disruption with a PCR-generated gno1::NAT allele. P  PstI. Genomic DNA was analyzed by
Southern blot. (The GNO1 gene is 7.2 kb [open arrowhead], and the gno1::NAT allele is 8.8 kb [closed arrowhead]). GSNO reductase activities
were assayed by GSNO-dependent NADH consumption (absorbance at 340 nm) with crude extracts (500 mg/ml) from wild-type (white), gno1
(black), fhb1 (gray), and fhb1  FHB1 reconstituted (stripes) strains incubated with 0.2 mM NADH with or without 0.15 mM GSNO [4].
static effect of GSNO (1–5 mM) (Figure 2C), whereas molecule in a variety of mammalian systems. The gener-
ation of NO by inducible NO synthase (NOS) has beengno1 mutant cells proliferated normally. The fhb1 mutant
phenotype was complemented by reintroduction of the suggested to play a central role in macrophage-medi-
ated stasis or in the killing of a variety of microbial patho-wild-type FHB1 gene, and fhb1FHB1 reconstituted
cells proliferated normally in the presence of NO and gens, including bacterial pathogens. NO exerts a fungi-
static effect against C. neoformans in vitro [8, 11, 17,GSNO (Figures 2B and 2C). Neither the fhb1 nor the
gno1 mutant was hypersensitive to H2O2 (0.5 to 1 mM). 18], and there is some evidence of the importance of
NO in cryptococcal infection [19], yet C. neoformansIn an independent screen, a library of random insertional
mutants was tested for NO hypersensitivity. The FHB1 can replicate within the hostile intracellular environment
of the macrophage as a facultative intracellular patho-gene was independently identified twice in this screen,
validating its importance in counteracting the toxic ef- gen [7, 9, 10]. This paradox underscores our limited
understanding of when and how C. neoformans evadesfects of nitrosative challenge. Taken together, these find-
ings demonstrate that flavohemoglobin protects fungal the nonspecific host immune response.
Given our in vitro findings, we hypothesized that flavo-cells from nitrosative challenge but does not metabolize
GSNO. hemoglobin would play a role in protecting C. neo-
formans from NO during infection. We assessed viru-In contrast to the situation in S. cerevisiae, intracellular
GSNO does not accumulate upon exposure to extracel- lence by using a murine inhalation model in which
infection begins in the lung, spreads hematogenously,lular GSNO. Rather, C. neoformans evidently converts
GSNO to NO, which is then detoxified by flavohemog- and leads to lethal meningoencephalitis, thus mimicking
many aspects of human infection. A/Jcr and C57BL/6lobin (Figure 2D). Such “SNO lyase” activity has been
previously observed in E. coli [5, 15], and a similar mech- mice were infected with wild-type, fhb1 mutant, and
fhb1  FHB1 reconstituted strains, and in six indepen-anism has been established for protection by catalase
against superoxide, which is reduced by cellular constit- dent experiments the fhb1 mutant was less virulent than
the wild-type. For example, in an experiment using anuents to H2O2. The relative importance of these pathways
compared to flavohemoglobin denitrosylation may be inoculum size of 1 105 cells, the mean survival of A/Jcr
mice infected with the fhb1 mutant strain was 26.4 days,different in other organisms; unlike the C. neoformans
enzyme, GSNO reductase protects S. cerevisiae from compared to 21.6 days for the wild-type (p 0.0006 fhb1
versus wild-type) (Figure 3A). Virulence was restored tonitrosative stress [4], and mice, which use S-nitrosyla-
tion for signaling, do not have flavohemoglobin but the wild-type level in the fhb1  FHB1 reconstituted
strain, and the mean survival was 22.1 days (p  0.22rather utilize GSNO reductase to control the levels of
S-nitrosylated proteins [4, 16]. fhb1  FHB1 versus wild-type), demonstrating that the
virulence defect is attributable solely to the fhb1 mu-NO is produced by inducible or constitutive forms of
NO synthase and is an important signaling and effector tation.
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Figure 2. Flavohemoglobin Destroys NO and Renders Fungal Growth NO Resistant
(A) Cells of the wild-type (squares), fhb1 (triangles), and fhb1  FHB1 reconstituted (circles) strains were cultured to mid-log phase and
transferred to YPD medium without (closed symbols) or with (open symbols) 1 mM DETA NONOate. Data shown are representative of three
experiments.
(B) Wild-type, fhb1, fhb1  FHB1 reconstituted, gno1, and fhb1 gno1 mutant strains were cultured in YPD supplemented with 0 mM (white),
1 mM (black), or 3.75 mM DETA NONOate (stripes). Growth was plotted as the relative fold increase in cell number. Error bars indicate standard
error of the mean for triplicate determinations.
(C) Wild-type, fhb1, fhb1  FHB1 reconstituted, gno1, and fhb1 gno1 mutant strains were cultured in YPD supplemented with 0 mM (white),
1 mM (black), 3 mM (stripes), or 5 mM GSNO (gray). Growth was plotted as the relative fold increase in cell number. Error bars indicate
standard error of the mean for triplicate determinations.
(D) Flavohemoglobin (Fhb1) protects the cell from NO stress delivered either as NO or via release from GSNO. S-nitrosoglutathione reductase
(Gno1) plays an ancillary role. NO3  nitrite, GSSG  reduced glutathione, NH4  ammonium.
To test whether the virulence defect observed in mu- wild-type versus fhb1) (Figure 3B). These findings dem-
onstrate that flavohemoglobin contributes to fungal viru-tant strains lacking flavohemoglobin was solely due to
hypersensitivity to nitrosative challenge, we infected lence in a second mouse background. Moreover, with-
out the nitrosative components of immunity, the fhb1mice lacking both copies of the NOS2 gene encoding
the inducible form of NO synthase (iNOS) with wild-type mutant, compared to the wild-type, displayed no viru-
lence defect in the in vivo model, reinforcing the hypo-and the fhb1 mutant strain. Because the immune cells
in these mice are unable to express iNOS in response thesis that flavohemoglobin detoxifies NO generated by
host iNOS during infection.to pathogens, they do not generate reactive nitrogen
species typical of murine infection models. Although In contrast to the attenuated virulence of the fhb1
mutant strain, the gno1 mutant was as virulent as thethere was a clear virulence defect for the fhb1 mutant
(mean survival  31.7 days) compared to wild-type H99 wild-type (Figure 3C), in accord with our in vitro findings
that gno1 mutant cells proliferated normally in the pres-(mean survival  26.9 days) in the wild-type C57BL/6
background expressing iNOS (p 0.03 wild-type versus ence of NO. However, virulence of an fhb1 gno1 double
mutant lacking both enzymes was more attenuated thanfhb1), iNOS/ animals from the same mouse back-
ground infected with wild-type and fhb1 mutant had either the fhb1 or the gno1 single mutant (p  0.04 fhb1
gno1 versus fhb1) (p  0.001 fhb1 gno1 versus gno1)mean survival times of 20 and 21 days, respectively, a
difference that was not statistically significant (p 0.27 (Figure 3C). Thus, in the absence of flavohemoglobin,
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Figure 4. Flavohemoglobin Promotes C. neoformans Survival in Ac-
tivated Macrophages by Counteracting Nitrosative Challenge
(A) Nitrite levels were measured in uninfected macrophages. Results
shown are from three experiments, and error bars represent the
standard error of the mean.
(B) Number of C. neoformans cells (CFU/ml) recovered from unstim-
ulated and stimulated MH-S macrophages incubated with wild-type,
fhb1, and fhb1  FHB1 reconstituted strains after 24 hr. Macro-
phages treated with the iNOS inhibitor L-NMMA are indicated. Re-
sults shown are from one experiment performed in duplicate and
are representative of three similar experiments. An asterisk denotes
a statistically significant difference in survival of the fhb1 mutant in
stimulated macrophages compared to the wild-type (p  0.005) or
the fhb1FHB1 (p  0.004) strains.Figure 3. Flavohemoglobin Enhances Fungal Virulence
(A) Groups of ten A/Jcr mice were infected by inhalation with 1 
105 cells of the wild-type, fhb1 mutant, fhb1  FHB1 reconstituted,
and the sod1 and fhb1 sod1 mutant strains, and survival was moni- choalveolar lavage fluid contained nitrite in infected but
tored. not in sham-infected animals (not shown), confirming
(B) Congenic C57BL/6 wild-type or iNOS/ mice were infected by that infected animals mount nitrosative challenge. Taken
inhalation with 1 105 cells of the wild-type and fhb1 mutant strains
together, these results indicate that NO and GSNO areand survival was monitored. The mean survival of iNOS/ mice
present during murine infection and that reducing path-infected with the fhb1 mutant was 21 days compared to 20 days
for the animals infected with wild-type (p0.26). By comparison, ways for both NO and GSNO contribute to the virulence
survival was prolonged in the C57BL/6 mice infected with either of cryptococcal disease.
wild-type (mean survival26.9 days) or fhb1 mutant cells (mean The majority of the inflammatory cells responding to
survival31.7 days), and difference in virulence between the wild- pulmonary cryptococcal infection are alveolar macro-
type and mutant strain was statistically significant (p0.03).
phages [20], and their principal effector molecules(C) Survival of mice infected with 5  105 cells of the wild-type,
include reactive nitrogen species [8]. In murine macro-fhb1, gno1, and fhb1 gno1 mutant strains. The mean survival of
mice infected with the fhb1 gno1 double mutant was 22.2 days phages, cytokines and engulfed microorganisms acti-
compared to 14.9, 15.4, and 19.8 days for the groups infected with vate transcription of NOS2. These activated macro-
wild-type (p 0.001), gno1 (p 0.001), and fhb1 mutants (p 0.04). phages produce NO and GSNO to kill intracellular
pathogens, and C. neoformans is found within cells at all
stages of infection, but the importance of macrophage-GSNO reductase can partially compensate to promote
survival of C. neoformans in the infected host. Presum- derived NO in suppressing fungal infection was unclear.
In a murine macrophage (MH-S) cell line, NO productionably, the levels of nitrosative species in the in vivo model
were not high enough to cause the complete growth was stimulated with LPS and -interferon (Figure 4A).
Compared to growth of wild-type and fhb1FHB1 re-inhibition observed in vitro, and the inoculation was le-
thal in all animals. We confirmed that serum and bron- constituted strains within activated macrophages, that
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of the fhb1 mutant was significantly reduced (Figure 4B), with metabolic and physical defenses to enable their
proliferation and the ultimate destruction of the hostas measured by recovered colony-forming units (4.75
102 versus 1.09  103 and 1.10  103; p  0.005 and macrophage.
NO and related molecules play a broad role in combat-0.004, respectively). The NOS inhibitor L-NMMA blocked
the nitrosative growth inhibition by endogenous reactive ing infection by diverse microbial pathogens. Activation
of NO production by macrophages during Paracoccidi-nitrogen intermediates (RNI) and restored growth of fhb1
mutant cells. The number of C. neoformans cells recov- odes brasiliensis infection contributes to direct killing
of the fungal pathogen [26]; however, persistent, high-ered from unstimulated macrophages was similar for all
strains tested, and there were no differences in the abil- level NO production has also been associated with host
immunosuppression and susceptibility to infection [27].ity of unstimulated, stimulated, or L-NMMA-treated
macrophages to phagocytose opsonized cells of any The observation that NO and GSNO protect against fun-
gal infection is in accord with the finding that the extentstrain tested (data not shown). Thus, the difference in
recovered fhb1 and wild-type cells in stimulated macro- of C. neoformans growth inhibition by human cytokine-
activated astrocytes correlates with production of nitritephages is attributable to the fungistatic effects of NO.
The enzymes superoxide dismutase (Sod1) and cata- and can be reversed by inhibitors of NOS [28]. Related
studies have recently discovered that individuals with alase play established roles in protecting fungal cells
from oxidative challenge, and SOD1 (which encodes the specific genetic mutation in the promoter of the NOS2
gene (1173 C-T) overproduce reactive nitrogen spe-Cu,Zn SOD) has recently been implicated in promoting
cryptococcal virulence and intracellular survival in mac- cies and are largely protected from cerebral infection by
the ubiquitous human pathogen Plasmodium falciparumrophages [21]. Synergistic cytotoxic effects of NO and
superoxide have been the subject of many studies, [29], whereas individuals with a different NOS2 promoter
mutation (1659 A-T) are more susceptible to cerebraland our mutant strains lacking both flavohemoglobin
and superoxide dismutase (fhb1 sod1) were significantly malaria [30]. Earlier studies showed that a flavohemo-
protein contributes to pathogenicity of Erwinia chrysan-more attenuated for virulence than the fhb1 single mu-
tant (p  0.0002 for fhb1 versus fhb1 sod1). When com- themi on plants, although a role for this protein in NO
catabolism was unknown at that time [31]. The subse-pared to the sod1 single mutant, whose virulence was
attenuated compared to that of the wild-type H99 strain quent discovery that plants elaborate NO as a defense
mechanism [32] suggests that the role of flavohemo-(p  0.002), the fhb1 sod1 mutant also displayed re-
duced virulence (Figure 3A). The time to the first lethal globin in promoting infection might be conserved from
a plant bacterial pathogen to a human fungal pathogen.infection was prolonged from day 22 to day 33, and at
the point where 50% of the sod1 infected animals had Our studies reveal mechanisms employed by a model
fungal pathogen to evade host innate immunity and sug-died, 100% of those infected with the fhb1 sod1 double
mutant were still viable. This being said, the final time gest that similar mechanisms may operate in other bac-
terial, parasitic, and fungal pathogens [33–35]. Strate-course to 100% lethal infection was comparable for both
strains. In summary, both Sod1 and flavohemoglobin gies directed at increasing nitrosative stress in microbial
pathogens may provide a novel approach to treatingcontribute to protect C. neoformans in vivo, and the two
enzymes function, at least in part, in an additive fashion. infection.
Furthermore, the gno1 sod1 mutant was intermediate
between the wild-type and fhb1 sod1 mutants (data not
Supplemental Datashown), underscoring a greater role for flavohemoglobin
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